LRP1 antagonists (Novoron Bioscience)

N/A

Report date: 2025/01/26 16:01:27
NME

Base Information

Drug NameLRP1 antagonists (Novoron Bioscience)
Drug Alias NameNOVO-117
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLow density lipoprotein receptor-related protein-1 inhibitors
TargetsLow density lipoprotein receptor-related protein-1
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovoron Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovoron Bioscience Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A